0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sirolimus Eluting Coronary Stent Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-17D10838
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Sirolimus Eluting Coronary Stent Market Research Report 2022
BUY CHAPTERS

Global Sirolimus Eluting Coronary Stent Market Research Report 2025

Code: QYRE-Auto-17D10838
Report
February 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sirolimus Eluting Coronary Stent Market Size

The global market for Sirolimus Eluting Coronary Stent was valued at US$ 108 million in the year 2024 and is projected to reach a revised size of US$ 137 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Sirolimus Eluting Coronary Stent Market

Sirolimus Eluting Coronary Stent Market

Sirolimus eluting coronary stent is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Sirolimus eluting coronary stent is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.
The sirolimus-eluting coronary stent is a medical device used in interventional cardiovascular surgery and belongs to a type of drug-eluting stent. A coronary stent is a device used to treat narrowed or blocked coronary arteries that is placed in the coronary arteries by percutaneous coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI). A stent can help restore patency to blood vessels so blood flow can resume. Sirolimus is an immunosuppressant that inhibits cell proliferation. A sirolimus-eluting coronary stent is a drug-eluting stent whose surface is coated with the drug sirolimus. When a stent is placed in a narrowed coronary artery, sirolimus is gradually eluted and released onto the vessel wall. The drug release of sirolimus helps to inhibit cell proliferation within blood vessels, reducing the risk of restenosis, thereby increasing the long-lasting effect of the procedure.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sirolimus Eluting Coronary Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sirolimus Eluting Coronary Stent.
The Sirolimus Eluting Coronary Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sirolimus Eluting Coronary Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sirolimus Eluting Coronary Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sirolimus Eluting Coronary Stent Market Report

Report Metric Details
Report Name Sirolimus Eluting Coronary Stent Market
Accounted market size in year US$ 108 million
Forecasted market size in 2031 US$ 137 million
CAGR 3.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Balloon Diameter 2.25-3 mm
  • Balloon Diameter 3-4 mm
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Cardionovum, Concept Medical, BIOTRONIK, Terumo Europe, Meril Life Sciences, eucatech AG, Eurocor Tech, MedAlliance, Boston Scientific, Abbott, Vasmed, Alvimedica, B. Braun, Balton
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sirolimus Eluting Coronary Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sirolimus Eluting Coronary Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Sirolimus Eluting Coronary Stent Market growing?

Ans: The Sirolimus Eluting Coronary Stent Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Sirolimus Eluting Coronary Stent Market size in 2031?

Ans: The Sirolimus Eluting Coronary Stent Market size in 2031 will be US$ 137 million.

Who are the main players in the Sirolimus Eluting Coronary Stent Market report?

Ans: The main players in the Sirolimus Eluting Coronary Stent Market are Cardionovum, Concept Medical, BIOTRONIK, Terumo Europe, Meril Life Sciences, eucatech AG, Eurocor Tech, MedAlliance, Boston Scientific, Abbott, Vasmed, Alvimedica, B. Braun, Balton

What are the Application segmentation covered in the Sirolimus Eluting Coronary Stent Market report?

Ans: The Applications covered in the Sirolimus Eluting Coronary Stent Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Sirolimus Eluting Coronary Stent Market report?

Ans: The Types covered in the Sirolimus Eluting Coronary Stent Market report are Balloon Diameter 2.25-3 mm, Balloon Diameter 3-4 mm, Others

1 Sirolimus Eluting Coronary Stent Market Overview
1.1 Product Definition
1.2 Sirolimus Eluting Coronary Stent by Type
1.2.1 Global Sirolimus Eluting Coronary Stent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Balloon Diameter 2.25-3 mm
1.2.3 Balloon Diameter 3-4 mm
1.2.4 Others
1.3 Sirolimus Eluting Coronary Stent by Application
1.3.1 Global Sirolimus Eluting Coronary Stent Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Sirolimus Eluting Coronary Stent Market Size Estimates and Forecasts
1.4.1 Global Sirolimus Eluting Coronary Stent Revenue 2020-2031
1.4.2 Global Sirolimus Eluting Coronary Stent Sales 2020-2031
1.4.3 Global Sirolimus Eluting Coronary Stent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sirolimus Eluting Coronary Stent Market Competition by Manufacturers
2.1 Global Sirolimus Eluting Coronary Stent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sirolimus Eluting Coronary Stent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sirolimus Eluting Coronary Stent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sirolimus Eluting Coronary Stent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sirolimus Eluting Coronary Stent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sirolimus Eluting Coronary Stent, Product Type & Application
2.7 Global Key Manufacturers of Sirolimus Eluting Coronary Stent, Date of Enter into This Industry
2.8 Global Sirolimus Eluting Coronary Stent Market Competitive Situation and Trends
2.8.1 Global Sirolimus Eluting Coronary Stent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sirolimus Eluting Coronary Stent Players Market Share by Revenue
2.8.3 Global Sirolimus Eluting Coronary Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sirolimus Eluting Coronary Stent Market Scenario by Region
3.1 Global Sirolimus Eluting Coronary Stent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sirolimus Eluting Coronary Stent Sales by Region: 2020-2031
3.2.1 Global Sirolimus Eluting Coronary Stent Sales by Region: 2020-2025
3.2.2 Global Sirolimus Eluting Coronary Stent Sales by Region: 2026-2031
3.3 Global Sirolimus Eluting Coronary Stent Revenue by Region: 2020-2031
3.3.1 Global Sirolimus Eluting Coronary Stent Revenue by Region: 2020-2025
3.3.2 Global Sirolimus Eluting Coronary Stent Revenue by Region: 2026-2031
3.4 North America Sirolimus Eluting Coronary Stent Market Facts & Figures by Country
3.4.1 North America Sirolimus Eluting Coronary Stent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sirolimus Eluting Coronary Stent Sales by Country (2020-2031)
3.4.3 North America Sirolimus Eluting Coronary Stent Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sirolimus Eluting Coronary Stent Market Facts & Figures by Country
3.5.1 Europe Sirolimus Eluting Coronary Stent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sirolimus Eluting Coronary Stent Sales by Country (2020-2031)
3.5.3 Europe Sirolimus Eluting Coronary Stent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sirolimus Eluting Coronary Stent Market Facts & Figures by Region
3.6.1 Asia Pacific Sirolimus Eluting Coronary Stent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sirolimus Eluting Coronary Stent Sales by Region (2020-2031)
3.6.3 Asia Pacific Sirolimus Eluting Coronary Stent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sirolimus Eluting Coronary Stent Market Facts & Figures by Country
3.7.1 Latin America Sirolimus Eluting Coronary Stent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sirolimus Eluting Coronary Stent Sales by Country (2020-2031)
3.7.3 Latin America Sirolimus Eluting Coronary Stent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sirolimus Eluting Coronary Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Sirolimus Eluting Coronary Stent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sirolimus Eluting Coronary Stent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sirolimus Eluting Coronary Stent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sirolimus Eluting Coronary Stent Sales by Type (2020-2031)
4.1.1 Global Sirolimus Eluting Coronary Stent Sales by Type (2020-2025)
4.1.2 Global Sirolimus Eluting Coronary Stent Sales by Type (2026-2031)
4.1.3 Global Sirolimus Eluting Coronary Stent Sales Market Share by Type (2020-2031)
4.2 Global Sirolimus Eluting Coronary Stent Revenue by Type (2020-2031)
4.2.1 Global Sirolimus Eluting Coronary Stent Revenue by Type (2020-2025)
4.2.2 Global Sirolimus Eluting Coronary Stent Revenue by Type (2026-2031)
4.2.3 Global Sirolimus Eluting Coronary Stent Revenue Market Share by Type (2020-2031)
4.3 Global Sirolimus Eluting Coronary Stent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sirolimus Eluting Coronary Stent Sales by Application (2020-2031)
5.1.1 Global Sirolimus Eluting Coronary Stent Sales by Application (2020-2025)
5.1.2 Global Sirolimus Eluting Coronary Stent Sales by Application (2026-2031)
5.1.3 Global Sirolimus Eluting Coronary Stent Sales Market Share by Application (2020-2031)
5.2 Global Sirolimus Eluting Coronary Stent Revenue by Application (2020-2031)
5.2.1 Global Sirolimus Eluting Coronary Stent Revenue by Application (2020-2025)
5.2.2 Global Sirolimus Eluting Coronary Stent Revenue by Application (2026-2031)
5.2.3 Global Sirolimus Eluting Coronary Stent Revenue Market Share by Application (2020-2031)
5.3 Global Sirolimus Eluting Coronary Stent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Cardionovum
6.1.1 Cardionovum Company Information
6.1.2 Cardionovum Description and Business Overview
6.1.3 Cardionovum Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cardionovum Sirolimus Eluting Coronary Stent Product Portfolio
6.1.5 Cardionovum Recent Developments/Updates
6.2 Concept Medical
6.2.1 Concept Medical Company Information
6.2.2 Concept Medical Description and Business Overview
6.2.3 Concept Medical Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Concept Medical Sirolimus Eluting Coronary Stent Product Portfolio
6.2.5 Concept Medical Recent Developments/Updates
6.3 BIOTRONIK
6.3.1 BIOTRONIK Company Information
6.3.2 BIOTRONIK Description and Business Overview
6.3.3 BIOTRONIK Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BIOTRONIK Sirolimus Eluting Coronary Stent Product Portfolio
6.3.5 BIOTRONIK Recent Developments/Updates
6.4 Terumo Europe
6.4.1 Terumo Europe Company Information
6.4.2 Terumo Europe Description and Business Overview
6.4.3 Terumo Europe Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Terumo Europe Sirolimus Eluting Coronary Stent Product Portfolio
6.4.5 Terumo Europe Recent Developments/Updates
6.5 Meril Life Sciences
6.5.1 Meril Life Sciences Company Information
6.5.2 Meril Life Sciences Description and Business Overview
6.5.3 Meril Life Sciences Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Meril Life Sciences Sirolimus Eluting Coronary Stent Product Portfolio
6.5.5 Meril Life Sciences Recent Developments/Updates
6.6 eucatech AG
6.6.1 eucatech AG Company Information
6.6.2 eucatech AG Description and Business Overview
6.6.3 eucatech AG Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 eucatech AG Sirolimus Eluting Coronary Stent Product Portfolio
6.6.5 eucatech AG Recent Developments/Updates
6.7 Eurocor Tech
6.7.1 Eurocor Tech Company Information
6.7.2 Eurocor Tech Description and Business Overview
6.7.3 Eurocor Tech Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Eurocor Tech Sirolimus Eluting Coronary Stent Product Portfolio
6.7.5 Eurocor Tech Recent Developments/Updates
6.8 MedAlliance
6.8.1 MedAlliance Company Information
6.8.2 MedAlliance Description and Business Overview
6.8.3 MedAlliance Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MedAlliance Sirolimus Eluting Coronary Stent Product Portfolio
6.8.5 MedAlliance Recent Developments/Updates
6.9 Boston Scientific
6.9.1 Boston Scientific Company Information
6.9.2 Boston Scientific Description and Business Overview
6.9.3 Boston Scientific Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boston Scientific Sirolimus Eluting Coronary Stent Product Portfolio
6.9.5 Boston Scientific Recent Developments/Updates
6.10 Abbott
6.10.1 Abbott Company Information
6.10.2 Abbott Description and Business Overview
6.10.3 Abbott Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Abbott Sirolimus Eluting Coronary Stent Product Portfolio
6.10.5 Abbott Recent Developments/Updates
6.11 Vasmed
6.11.1 Vasmed Company Information
6.11.2 Vasmed Description and Business Overview
6.11.3 Vasmed Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Vasmed Sirolimus Eluting Coronary Stent Product Portfolio
6.11.5 Vasmed Recent Developments/Updates
6.12 Alvimedica
6.12.1 Alvimedica Company Information
6.12.2 Alvimedica Description and Business Overview
6.12.3 Alvimedica Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Alvimedica Sirolimus Eluting Coronary Stent Product Portfolio
6.12.5 Alvimedica Recent Developments/Updates
6.13 B. Braun
6.13.1 B. Braun Company Information
6.13.2 B. Braun Description and Business Overview
6.13.3 B. Braun Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.13.4 B. Braun Sirolimus Eluting Coronary Stent Product Portfolio
6.13.5 B. Braun Recent Developments/Updates
6.14 Balton
6.14.1 Balton Company Information
6.14.2 Balton Description and Business Overview
6.14.3 Balton Sirolimus Eluting Coronary Stent Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Balton Sirolimus Eluting Coronary Stent Product Portfolio
6.14.5 Balton Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sirolimus Eluting Coronary Stent Industry Chain Analysis
7.2 Sirolimus Eluting Coronary Stent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sirolimus Eluting Coronary Stent Production Mode & Process Analysis
7.4 Sirolimus Eluting Coronary Stent Sales and Marketing
7.4.1 Sirolimus Eluting Coronary Stent Sales Channels
7.4.2 Sirolimus Eluting Coronary Stent Distributors
7.5 Sirolimus Eluting Coronary Stent Customer Analysis
8 Sirolimus Eluting Coronary Stent Market Dynamics
8.1 Sirolimus Eluting Coronary Stent Industry Trends
8.2 Sirolimus Eluting Coronary Stent Market Drivers
8.3 Sirolimus Eluting Coronary Stent Market Challenges
8.4 Sirolimus Eluting Coronary Stent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Sirolimus Eluting Coronary Stent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sirolimus Eluting Coronary Stent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sirolimus Eluting Coronary Stent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sirolimus Eluting Coronary Stent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Sirolimus Eluting Coronary Stent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sirolimus Eluting Coronary Stent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sirolimus Eluting Coronary Stent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sirolimus Eluting Coronary Stent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sirolimus Eluting Coronary Stent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sirolimus Eluting Coronary Stent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sirolimus Eluting Coronary Stent, Product Type & Application
 Table 12. Global Key Manufacturers of Sirolimus Eluting Coronary Stent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sirolimus Eluting Coronary Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sirolimus Eluting Coronary Stent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sirolimus Eluting Coronary Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sirolimus Eluting Coronary Stent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Sirolimus Eluting Coronary Stent Sales Market Share by Region (2020-2025)
 Table 19. Global Sirolimus Eluting Coronary Stent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Sirolimus Eluting Coronary Stent Sales Market Share by Region (2026-2031)
 Table 21. Global Sirolimus Eluting Coronary Stent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Region (2020-2025)
 Table 23. Global Sirolimus Eluting Coronary Stent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Region (2026-2031)
 Table 25. North America Sirolimus Eluting Coronary Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sirolimus Eluting Coronary Stent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Sirolimus Eluting Coronary Stent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Sirolimus Eluting Coronary Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sirolimus Eluting Coronary Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sirolimus Eluting Coronary Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sirolimus Eluting Coronary Stent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Sirolimus Eluting Coronary Stent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Sirolimus Eluting Coronary Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sirolimus Eluting Coronary Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sirolimus Eluting Coronary Stent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sirolimus Eluting Coronary Stent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Sirolimus Eluting Coronary Stent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Sirolimus Eluting Coronary Stent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sirolimus Eluting Coronary Stent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sirolimus Eluting Coronary Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sirolimus Eluting Coronary Stent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Sirolimus Eluting Coronary Stent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Sirolimus Eluting Coronary Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sirolimus Eluting Coronary Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sirolimus Eluting Coronary Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sirolimus Eluting Coronary Stent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Sirolimus Eluting Coronary Stent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Sirolimus Eluting Coronary Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sirolimus Eluting Coronary Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sirolimus Eluting Coronary Stent Sales (K Units) by Type (2020-2025)
 Table 51. Global Sirolimus Eluting Coronary Stent Sales (K Units) by Type (2026-2031)
 Table 52. Global Sirolimus Eluting Coronary Stent Sales Market Share by Type (2020-2025)
 Table 53. Global Sirolimus Eluting Coronary Stent Sales Market Share by Type (2026-2031)
 Table 54. Global Sirolimus Eluting Coronary Stent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sirolimus Eluting Coronary Stent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Type (2020-2025)
 Table 57. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Type (2026-2031)
 Table 58. Global Sirolimus Eluting Coronary Stent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Sirolimus Eluting Coronary Stent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Sirolimus Eluting Coronary Stent Sales (K Units) by Application (2020-2025)
 Table 61. Global Sirolimus Eluting Coronary Stent Sales (K Units) by Application (2026-2031)
 Table 62. Global Sirolimus Eluting Coronary Stent Sales Market Share by Application (2020-2025)
 Table 63. Global Sirolimus Eluting Coronary Stent Sales Market Share by Application (2026-2031)
 Table 64. Global Sirolimus Eluting Coronary Stent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sirolimus Eluting Coronary Stent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Application (2020-2025)
 Table 67. Global Sirolimus Eluting Coronary Stent Revenue Market Share by Application (2026-2031)
 Table 68. Global Sirolimus Eluting Coronary Stent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Sirolimus Eluting Coronary Stent Price (US$/Unit) by Application (2026-2031)
 Table 70. Cardionovum Company Information
 Table 71. Cardionovum Description and Business Overview
 Table 72. Cardionovum Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Cardionovum Sirolimus Eluting Coronary Stent Product
 Table 74. Cardionovum Recent Developments/Updates
 Table 75. Concept Medical Company Information
 Table 76. Concept Medical Description and Business Overview
 Table 77. Concept Medical Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Concept Medical Sirolimus Eluting Coronary Stent Product
 Table 79. Concept Medical Recent Developments/Updates
 Table 80. BIOTRONIK Company Information
 Table 81. BIOTRONIK Description and Business Overview
 Table 82. BIOTRONIK Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BIOTRONIK Sirolimus Eluting Coronary Stent Product
 Table 84. BIOTRONIK Recent Developments/Updates
 Table 85. Terumo Europe Company Information
 Table 86. Terumo Europe Description and Business Overview
 Table 87. Terumo Europe Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Terumo Europe Sirolimus Eluting Coronary Stent Product
 Table 89. Terumo Europe Recent Developments/Updates
 Table 90. Meril Life Sciences Company Information
 Table 91. Meril Life Sciences Description and Business Overview
 Table 92. Meril Life Sciences Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Meril Life Sciences Sirolimus Eluting Coronary Stent Product
 Table 94. Meril Life Sciences Recent Developments/Updates
 Table 95. eucatech AG Company Information
 Table 96. eucatech AG Description and Business Overview
 Table 97. eucatech AG Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. eucatech AG Sirolimus Eluting Coronary Stent Product
 Table 99. eucatech AG Recent Developments/Updates
 Table 100. Eurocor Tech Company Information
 Table 101. Eurocor Tech Description and Business Overview
 Table 102. Eurocor Tech Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Eurocor Tech Sirolimus Eluting Coronary Stent Product
 Table 104. Eurocor Tech Recent Developments/Updates
 Table 105. MedAlliance Company Information
 Table 106. MedAlliance Description and Business Overview
 Table 107. MedAlliance Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. MedAlliance Sirolimus Eluting Coronary Stent Product
 Table 109. MedAlliance Recent Developments/Updates
 Table 110. Boston Scientific Company Information
 Table 111. Boston Scientific Description and Business Overview
 Table 112. Boston Scientific Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Boston Scientific Sirolimus Eluting Coronary Stent Product
 Table 114. Boston Scientific Recent Developments/Updates
 Table 115. Abbott Company Information
 Table 116. Abbott Description and Business Overview
 Table 117. Abbott Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Abbott Sirolimus Eluting Coronary Stent Product
 Table 119. Abbott Recent Developments/Updates
 Table 120. Vasmed Company Information
 Table 121. Vasmed Description and Business Overview
 Table 122. Vasmed Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Vasmed Sirolimus Eluting Coronary Stent Product
 Table 124. Vasmed Recent Developments/Updates
 Table 125. Alvimedica Company Information
 Table 126. Alvimedica Description and Business Overview
 Table 127. Alvimedica Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Alvimedica Sirolimus Eluting Coronary Stent Product
 Table 129. Alvimedica Recent Developments/Updates
 Table 130. B. Braun Company Information
 Table 131. B. Braun Description and Business Overview
 Table 132. B. Braun Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. B. Braun Sirolimus Eluting Coronary Stent Product
 Table 134. B. Braun Recent Developments/Updates
 Table 135. Balton Company Information
 Table 136. Balton Description and Business Overview
 Table 137. Balton Sirolimus Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Balton Sirolimus Eluting Coronary Stent Product
 Table 139. Balton Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Sirolimus Eluting Coronary Stent Distributors List
 Table 143. Sirolimus Eluting Coronary Stent Customers List
 Table 144. Sirolimus Eluting Coronary Stent Market Trends
 Table 145. Sirolimus Eluting Coronary Stent Market Drivers
 Table 146. Sirolimus Eluting Coronary Stent Market Challenges
 Table 147. Sirolimus Eluting Coronary Stent Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sirolimus Eluting Coronary Stent
 Figure 2. Global Sirolimus Eluting Coronary Stent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sirolimus Eluting Coronary Stent Market Share by Type: 2024 & 2031
 Figure 4. Balloon Diameter 2.25-3 mm Product Picture
 Figure 5. Balloon Diameter 3-4 mm Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Sirolimus Eluting Coronary Stent Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Sirolimus Eluting Coronary Stent Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Clinics
 Figure 11. Others
 Figure 12. Global Sirolimus Eluting Coronary Stent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Sirolimus Eluting Coronary Stent Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Sirolimus Eluting Coronary Stent Sales (2020-2031) & (K Units)
 Figure 15. Global Sirolimus Eluting Coronary Stent Average Price (US$/Unit) & (2020-2031)
 Figure 16. Sirolimus Eluting Coronary Stent Report Years Considered
 Figure 17. Sirolimus Eluting Coronary Stent Sales Share by Manufacturers in 2024
 Figure 18. Global Sirolimus Eluting Coronary Stent Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Sirolimus Eluting Coronary Stent Players: Market Share by Revenue in Sirolimus Eluting Coronary Stent in 2024
 Figure 20. Sirolimus Eluting Coronary Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Sirolimus Eluting Coronary Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Sirolimus Eluting Coronary Stent Sales Market Share by Country (2020-2031)
 Figure 23. North America Sirolimus Eluting Coronary Stent Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Sirolimus Eluting Coronary Stent Sales Market Share by Country (2020-2031)
 Figure 27. Europe Sirolimus Eluting Coronary Stent Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Sirolimus Eluting Coronary Stent Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Sirolimus Eluting Coronary Stent Revenue Market Share by Region (2020-2031)
 Figure 35. China Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Sirolimus Eluting Coronary Stent Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Sirolimus Eluting Coronary Stent Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Sirolimus Eluting Coronary Stent Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Sirolimus Eluting Coronary Stent Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Sirolimus Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Sirolimus Eluting Coronary Stent by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Sirolimus Eluting Coronary Stent by Type (2020-2031)
 Figure 57. Global Sirolimus Eluting Coronary Stent Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Sirolimus Eluting Coronary Stent by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Sirolimus Eluting Coronary Stent by Application (2020-2031)
 Figure 60. Global Sirolimus Eluting Coronary Stent Price (US$/Unit) by Application (2020-2031)
 Figure 61. Sirolimus Eluting Coronary Stent Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global AF HDL and LDL/VLDL Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27N18700
Fri Feb 21 00:00:00 UTC 2025

Add to Cart

Global Rigid Intracardiac Echocardiography (ICE) Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37W13091
Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Intracardiac Echocardiography (ICE) Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16J13119
Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Angiography Tubing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1D10536
Tue Feb 18 00:00:00 UTC 2025

Add to Cart